Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis (Q77930168)
scientific article published on 01 April 2002
Language:
(P31) (Q13442814)
(P304) 667-677
(P407) (Q1860)
(P433) 4
(P478) 29
(P577) Monday, April 1, 2002
(P921) (Q187255)
(P1433) (Q7743623)
(P1476) "Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis" (language: en)
(P2093) William J Shergy
Reuben A Isern
David A Cooley
John L Harshbarger
J Eugene Huffstutter
Gordon M Hughes
Elizabeth A Spencer-Smith
Allan L Goldman
Sanford H Roth
J Scott Toder
Diana Warner
Adrienne Quinn
Gregory F Keenan
Thomas F Schaible
PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial
other details
description scientific article published on 01 April 2002

External Links